Suppr超能文献

谱系决定因子在胰腺导管腺癌中的作用。

The role of lineage specifiers in pancreatic ductal adenocarcinoma.

作者信息

Camolotto Soledad A, Belova Veronika K, Snyder Eric L

机构信息

Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Department of Pathology, University of Utah, Salt Lake City, UT, USA.

出版信息

J Gastrointest Oncol. 2018 Dec;9(6):1005-1013. doi: 10.21037/jgo.2018.05.04.

Abstract

Over the last decade, multiple genomics studies have led to the identification of discrete molecular subtypes of pancreatic ductal adenocarcinoma. A general theme has emerged that most pancreatic ductal adenocarcinoma (PDAC) can be grouped into two major subtypes based on cancer cell autonomous properties: classical/pancreatic progenitor and basal-like/squamous. The classical/progenitor subtype expresses higher levels of lineage specifiers that regulate endodermal differentiation than the basal-like/squamous subtype. The basal-like/squamous subtype confers a worse prognosis, raising the possibility that loss of these lineage specifiers might enhance the malignant potential of PDAC. Here, we discuss several of these differentially expressed lineage specifiers and examine the evidence that they might play a functional role in PDAC biology.

摘要

在过去十年中,多项基因组学研究已导致鉴定出胰腺导管腺癌的不同分子亚型。一个普遍的主题已经出现,即大多数胰腺导管腺癌(PDAC)可根据癌细胞自主特性分为两种主要亚型:经典/胰腺祖细胞型和基底样/鳞状型。经典/祖细胞亚型比基底样/鳞状亚型表达更高水平的调节内胚层分化的谱系特异性因子。基底样/鳞状亚型预后较差,这增加了这些谱系特异性因子的缺失可能增强PDAC恶性潜能的可能性。在这里,我们讨论其中几种差异表达的谱系特异性因子,并研究它们可能在PDAC生物学中发挥功能作用的证据。

相似文献

1
The role of lineage specifiers in pancreatic ductal adenocarcinoma.
J Gastrointest Oncol. 2018 Dec;9(6):1005-1013. doi: 10.21037/jgo.2018.05.04.
2
Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.
Gut. 2021 May;70(5):900-914. doi: 10.1136/gutjnl-2020-321316. Epub 2020 Aug 21.
3
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance.
Front Cell Dev Biol. 2021 Dec 2;9:795251. doi: 10.3389/fcell.2021.795251. eCollection 2021.
4
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.
Carcinogenesis. 2024 Nov 22;45(11):845-856. doi: 10.1093/carcin/bgae056.
5
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.
bioRxiv. 2024 Mar 13:2024.03.12.584316. doi: 10.1101/2024.03.12.584316.
7
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Cell Rep. 2020 May 12;31(6):107625. doi: 10.1016/j.celrep.2020.107625.
9
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of .
Cancer Res. 2020 Nov 1;80(21):4620-4632. doi: 10.1158/0008-5472.CAN-20-0672. Epub 2020 Sep 9.

引用本文的文献

2
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity.
Int J Cancer. 2023 Aug 1;153(3):552-570. doi: 10.1002/ijc.34528. Epub 2023 May 4.
3
Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets.
Int J Mol Sci. 2022 Sep 28;23(19):11438. doi: 10.3390/ijms231911438.
4
Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma.
iScience. 2022 Jun 22;25(8):104659. doi: 10.1016/j.isci.2022.104659. eCollection 2022 Aug 19.
5
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance.
Front Cell Dev Biol. 2021 Dec 2;9:795251. doi: 10.3389/fcell.2021.795251. eCollection 2021.
6
The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.
Int J Mol Sci. 2021 Jun 15;22(12):6374. doi: 10.3390/ijms22126374.
7
Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.
Gut. 2021 May;70(5):900-914. doi: 10.1136/gutjnl-2020-321316. Epub 2020 Aug 21.

本文引用的文献

2
Investigating the role of transcription factors of pancreas development in pancreatic cancer.
Pancreatology. 2018 Mar;18(2):184-190. doi: 10.1016/j.pan.2017.12.013. Epub 2017 Dec 24.
3
SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer.
J Cell Biol. 2018 Feb 5;217(2):763-777. doi: 10.1083/jcb.201705031. Epub 2017 Dec 11.
4
The molecular functions of hepatocyte nuclear factors - In and beyond the liver.
J Hepatol. 2018 May;68(5):1033-1048. doi: 10.1016/j.jhep.2017.11.026. Epub 2017 Nov 24.
5
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.
Biomedicines. 2017 Nov 18;5(4):65. doi: 10.3390/biomedicines5040065.
8
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies.
Cancer Treat Rev. 2017 Nov;60:32-43. doi: 10.1016/j.ctrv.2017.08.007. Epub 2017 Aug 23.
9
HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
J Cell Biochem. 2019 Mar;120(3):2816-2827. doi: 10.1002/jcb.26395. Epub 2018 Nov 30.
10
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
Cancer Cell. 2017 Aug 14;32(2):185-203.e13. doi: 10.1016/j.ccell.2017.07.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验